prof. dr. G.A. Huls

Faculteit Medische Wetenschappen/UMCG

Telefoon:

050 361 2354

E-mail:

g.huls umcg.nl

ORCID Research Portal

Publicaties

Bleximenib, the novel menin-KMT2A inhibitor JNJ-75276617, impairs long-term proliferation and immune evasion in acute myeloid leukemia

Hogeling, S. M., Lê, D. M., Rose, N. L., Kwon, M. C., Wierenga, A. T. J., van den Heuvel, F. A. J., van den Boom, V., Kuchnio, A., Philippar, U., Huls, G. & Schuringa, J. J., jun.-2025, In: Haematologica. 110, 6, blz. 1278-1291 14 blz.

Onderzoeksoutput: Article › › peer review

CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents

Reuvekamp, T., Ngai, L. L., den Hartog, D., Carbaat-Ham, J., Fayed, M. M. H. E., Scholten, W. J., Mocking, T. R., Chitu, D. A., Pabst, T., Klein, S. K., Stussi, G., Griskevicius, L., Breems, D., van Lammeren-Venema, D., Boersma, R., Ossenkoppele, G. J., van de Loosdrecht, A. A., Bachas, C., Huls, G. & de Leeuw, D. C. & 1 anderen, Cloos, J., apr.-2025, In: Leukemia. 39, 4, blz. 972-975 4 blz.

Onderzoeksoutput: Letter › › peer review

Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients

Hermans, S. J. F., Versluis, J., van Werkhoven, E. D., van Norden, Y., Janssen, J. J. W. M., Huls, G. A., Pabst, T., Breems, D. A., Berkx, E., Dinmohamed, A. G., Huijgens, P. C., Sträng, E., Hernández Rivas, J. M., Sobas, M., Ayala Diaz, R., Martinez Lopez, J., Metzeler, K. H., Haferlach, T., Thiede, C. & Uyl-de Groot, C. A. & 5 anderen, Bullinger, L., Löwenberg, B., Ossenkoppele, G. J., Pignatti, F. & Cornelissen, J. J., 26-mei-2025, (E-pub ahead of print) In: British Journal of Haematology.

Onderzoeksoutput: Article › › peer review

Consolidation With Second High Dose Therapy and Autologous Stem Cell Transplantation Is Associated With Improved Overall Survival in Patients With Multiple Myeloma in First Relapse

Klomberg, K. M., Gelderloos, M., Kooistra, H. A. M., Nijland, M., Huls, G. A., Roeloffzen, W. W. H. & Plattel, W. J., mei-2025, In: Clinical lymphoma, myeloma & leukemia. 25, 5, blz. 357-364.e5 13 blz.

Onderzoeksoutput: Article › › peer review

Corrigendum to “Skin autofluorescence, a measure for accumulation of advanced glycation end products, positively associates with blood neutrophil and monocyte counts in the general population, and particularly in men with prediabetes” [Atherosclerosis (2024) 395 117609] (Atherosclerosis (2024) 395, (S0021915024001692), (10.1016/j.atherosclerosis.2024.117609))

Groenen, A. G., Halmos, B., van Zeventer, I. A., Salzbrunn, J. B., Mayer, M. L., La Rose, N. D., Nolte, I. M., Schuringa, J. J., Huls, G. & Westerterp, M., apr.-2025, In: Atherosclerosis. 403, 5 blz., 119164.

Onderzoeksoutput: Erratum

Donor lymphocyte infusions after HLA-identical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in acute myeloid leukemia patients

Storck, T. N., Morsink, L. M., Biswana, A., Hazenberg, C. L. E., Huls, G. & Choi, G., mei-2025, In: Bone marrow transplantation. 60, blz. 737–739 3 blz.

Onderzoeksoutput: Comment/Letter to the editor › › peer review

Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

Venditti, A., Palmieri, R., Maurillo, L., Röllig, C., Wierzbowska, A., de Leeuw, D., Efficace, F., Curti, A., Lam Ngai, L., Tettero, J., Adès, L., Almeida, A., Bullinger, L., Dennis, M., Esteve, J., Ferrara, F., Heuser, M., Huls, G., Lübbert, M. & Mehta, P. & 13 anderen, Montesinos, P., Pabst, T., Récher, C., Rossi, G., Russell, N., Sierra, J., Stauder, R., Vey, N., Walter, R. B., Wang, E., Nier, S., Garcez Martins, C. & Ossenkoppele, G., 13-mei-2025, In: Blood Advances. 9, 9, blz. 2207-2220 14 blz.

Onderzoeksoutput: Review article › peer review

Galectin-9 treatment is cytotoxic for B cell lymphoma by disrupting autophagy

Koll, L., Lourens, H. J., Marsman, G., de Haan, S., Niki, T., Huls, G. A., Bremer, E. & Wiersma, V. R., 26-jun.-2025, In: Frontiers in Pharmacology. 16, 13 blz., 1601235.

Onderzoeksoutput: Article › › peer review

High expression of signal regulatory protein beta 2 marks a favourable prognostic AML subgroup and associates with increased sensitivity to phagocytosis

Visser, N., van der Meer, N. K., He, Y., Huls, G., Schuringa, J. J. & Bremer, E., 25-jun.-2025, In: Immunologic research. 73, 1, 7 blz., 98.

Onderzoeksoutput: Article › › peer review

Increased Clonal Hematopoiesis in Long-term Survivors of Pediatric Hematopoietic Cell Transplantation

Müskens, K. F., Wieringa, N., van Bergen, M. G. J. M., Bense, J. E., te Pas, B. M., de Pagter, A. P. J., Lankester, A. C., Bierings, M. B., Neuberg, D. S., Haitjema, S., Kremer, L. C. M., Huls, G. A., Nierkens, S., Jansen, J. H., Lindemans, C. A., de Graaf, A. O. & Belderbos, M. E., 1-mrt.-2025, In: Blood cancer discovery. 6, 2, blz. 110-118 9 blz.

Onderzoeksoutput: Article › › peer review